These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 12153829

  • 1. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
    Lecrubier Y, Clerc G, Didi R, Kieser M.
    Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
    [Abstract] [Full Text] [Related]

  • 2. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
    Kasper S, Anghelescu IG, Szegedi A, Dienel A, Kieser M.
    BMC Med; 2006 Jun 23; 4():14. PubMed ID: 16796730
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
    Kalb R, Trautmann-Sponsel RD, Kieser M.
    Pharmacopsychiatry; 2001 May 23; 34(3):96-103. PubMed ID: 11434406
    [Abstract] [Full Text] [Related]

  • 4. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.
    Szegedi A, Kohnen R, Dienel A, Kieser M.
    BMJ; 2005 Mar 05; 330(7490):503. PubMed ID: 15708844
    [Abstract] [Full Text] [Related]

  • 5. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.
    Eur Neuropsychopharmacol; 2008 Nov 05; 18(11):803-13. PubMed ID: 18694635
    [Abstract] [Full Text] [Related]

  • 6. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
    Gelenberg AJ, Shelton RC, Crits-Christoph P, Keller MB, Dunner DL, Hirschfeld RM, Thase ME, Russell JM, Lydiard RB, Gallop RJ, Todd L, Hellerstein DJ, Goodnick PJ, Keitner GI, Stahl SM, Halbreich U, Hopkins HS.
    J Clin Psychiatry; 2004 Aug 05; 65(8):1114-9. PubMed ID: 15323598
    [Abstract] [Full Text] [Related]

  • 7. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G, Schüle C, Baghai T, Kieser M.
    Pharmacopsychiatry; 1998 Jun 05; 31 Suppl 1():54-9. PubMed ID: 9684948
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of St John's wort in major depression: a randomized controlled trial.
    Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, Halbreich U.
    JAMA; 2001 Apr 18; 285(15):1978-86. PubMed ID: 11308434
    [Abstract] [Full Text] [Related]

  • 9. [Use of St. John's Wort for depression in primary care - a non-interventional study].
    Musselmann B, Rychlik R, Burkart M.
    MMW Fortschr Med; 2011 Dec 15; 153 Suppl 4():119-27. PubMed ID: 23964473
    [Abstract] [Full Text] [Related]

  • 10. Hypericum extract WS ® 5570 for depression--an overview.
    Gastpar M.
    Int J Psychiatry Clin Pract; 2013 Nov 15; 17 Suppl 1():1-7. PubMed ID: 23808616
    [Abstract] [Full Text] [Related]

  • 11. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.
    Singer A, Schmidt M, Hauke W, Stade K.
    Phytomedicine; 2011 Jun 15; 18(8-9):739-42. PubMed ID: 21514125
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
    Anghelescu IG, Kohnen R, Szegedi A, Klement S, Kieser M.
    Pharmacopsychiatry; 2006 Nov 15; 39(6):213-9. PubMed ID: 17124643
    [Abstract] [Full Text] [Related]

  • 13. St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.
    Mannel M, Kuhn U, Schmidt U, Ploch M, Murck H.
    J Psychiatr Res; 2010 Sep 15; 44(12):760-7. PubMed ID: 20181361
    [Abstract] [Full Text] [Related]

  • 14. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
    Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF.
    J Clin Psychopharmacol; 2005 Oct 15; 25(5):441-7. PubMed ID: 16160619
    [Abstract] [Full Text] [Related]

  • 15. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression.
    Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmström C, Panossian A.
    Nord J Psychiatry; 2007 Oct 15; 61(5):343-8. PubMed ID: 17990195
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.
    Randløv C, Mehlsen J, Thomsen CF, Hedman C, von Fircks H, Winther K.
    Phytomedicine; 2006 Mar 15; 13(4):215-21. PubMed ID: 16423519
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of Hypericum extract STW 3-VI in patients with moderate depression: a double-blind, randomized, placebo-controlled clinical trial.
    Uebelhack R, Gruenwald J, Graubaum HJ, Busch R.
    Adv Ther; 2004 Mar 15; 21(4):265-75. PubMed ID: 15605620
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials.
    Kasper S, Gastpar M, Müller WE, Volz HP, Dienel A, Kieser M, Möller HJ.
    Eur Arch Psychiatry Clin Neurosci; 2008 Feb 15; 258(1):59-63. PubMed ID: 18084790
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities.
    Laakmann G, Dienel A, Kieser M.
    Phytomedicine; 1998 Dec 15; 5(6):435-42. PubMed ID: 23196026
    [Abstract] [Full Text] [Related]

  • 20. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
    Hypericum Depression Trial Study Group, Davidson JR, Gadde KM, Fairbank JA, Krishnan KRR, Califf RM, Binanay C, Parker CB, Pugh N, Hartwell TD, Vitiello B, Ritz L, Severe J, Cole JO, de Battista C, Doraiswamy PM, Feighner JP, Keck P, Kelsey J, Lin KM, Londborg PD, Nemeroff CB, Schatzberg AF, Sheehan DV, Srivastava RK, Taylor L, Trivedi MH, Weisler RH.
    JAMA; 2002 Apr 10; 287(14):1807-14. PubMed ID: 11939866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.